Hypertriglyceridemia and waist circumference predict cardiovascular risk among HIV patients: A cross-sectional study

PLoS ONE

Volumn 6, Issue 9, 2011, Pages

  Janiszewski, Peter M ^a   Ross, Robert ^a   Despres, Jean Pierre ^b   Lemieux, Isabelle ^b   Orlando, Gabriella ^c   Carli, Federica ^c   Bagni, Pietro ^c   Menozzi, Marianna ^c   Zona, Stefano ^c   Guaraldi, Giovanni ^c  

^a QUEEN S UNIVERSITY   (Canada)

^b LAVAL UNIVERSITY   (Canada)

^c UNIVERSITY OF MODENA AND REGGIO EMILIA   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

TRIACYLGLYCEROL;

ABDOMINAL SUBCUTANEOUS FAT; ADULT; ARTICLE; CARDIOVASCULAR RISK; CONTROLLED STUDY; DISEASE ASSOCIATION; DISEASE SEVERITY; FEMALE; HIGH RISK PATIENT; HIV ASSOCIATED LIPODYSTROPHY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1 INFECTION; HUMAN IMMUNODEFICIENCY VIRUS INFECTED PATIENT; HYPERTENSION; HYPERTRIGLYCERIDEMIA; INFECTION COMPLICATION; INTRAABDOMINAL FAT; MAJOR CLINICAL STUDY; MALE; METABOLIC SYNDROME X; NON INSULIN DEPENDENT DIABETES MELLITUS; PROGNOSIS; RISK ASSESSMENT; TRIACYLGLYCEROL BLOOD LEVEL; WAIST CIRCUMFERENCE; ANTHROPOMETRY; BLOOD; BODY COMPOSITION; CARDIOVASCULAR DISEASE; COMPUTER ASSISTED TOMOGRAPHY; CROSS-SECTIONAL STUDY; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; METHODOLOGY; MIDDLE AGED; PREVALENCE; RISK FACTOR; SEX DIFFERENCE;

EMILIA;

ADULT; ANTHROPOMETRY; BODY COMPOSITION; CARDIOVASCULAR DISEASES; CROSS-SECTIONAL STUDIES; DIABETES MELLITUS, TYPE 2; FEMALE; HIV INFECTIONS; HUMANS; HYPERTRIGLYCERIDEMIA; MALE; METABOLIC SYNDROME X; MIDDLE AGED; PREVALENCE; RISK FACTORS; SEX FACTORS; TOMOGRAPHY, X-RAY COMPUTED; TRIGLYCERIDES; WAIST CIRCUMFERENCE;

EID: 80053081587     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0025032     Document Type: Article

References (23)

1. Miller J, Carr A, Emery S, Law M, Mallal S, et al. (2003) HIV lipodystrophy: prevalence, severity and correlates of risk in Australia. HIV Med 4: 293-301.
2. Miller KD, Jones E, Yanovski JA, Shankar R, Feuerstein I, et al. (1998) Visceral abdominal-fat accumulation associated with use of indinavir. Lancet 351: 871-875.
3. Joy T, Keogh HM, Hadigan C, Dolan SE, Fitch K, et al. (2008) Relation of body composition to body mass index in HIV-infected patients with metabolic abnormalities. J Acquir Immune Defic Syndr 47: 174-184.
4. Sutinen J, Hakkinen AM, Westerbacka J, Seppala-Lindroos A, Vehkavaara S, et al. (2002) Increased fat accumulation in the liver in HIV-infected patients with antiretroviral therapy-associated lipodystrophy. Aids 16: 2183-2193.
5. Gan SK, Samaras K, Thompson CH, Kraegen EW, Carr A, et al. (2002) Altered myocellular and abdominal fat partitioning predict disturbance in insulin action in HIV protease inhibitor-related lipodystrophy. Diabetes 51: 3163-3169.
6. Grinspoon S, Carr A, (2005) Cardiovascular risk and body-fat abnormalities in HIV-infected adults. N Engl J Med 352: 48-62.
7. Guaraldi G, Stentarelli C, Zona S, Orlando G, Carli F, et al. (2010) Lipodystrophy and anti-retroviral therapy as predictors of sub-clinical atherosclerosis in human immunodeficiency virus infected subjects. Atherosclerosis 208: 222-227.
8. Brown TT, Cole SR, Li X, Kingsley LA, Palella FJ, et al. (2005) Antiretroviral therapy and the prevalence and incidence of diabetes mellitus in the multicenter AIDS cohort study. Arch Intern Med 165: 1179-1184.
9. Triant VA, Lee H, Hadigan C, Grinspoon SK, (2007) Increased acute myocardial infarction rates and cardiovascular risk factors among patients with human immunodeficiency virus disease. J Clin Endocrinol Metab 92: 2506-2512.
10. Janiszewski PM, Janssen I, Ross R, (2007) Does waist circumference predict diabetes and cardiovascular disease beyond commonly evaluated cardiometabolic risk factors? Diabetes Care 30: 3105-3109.
11. Janssen I, Katzmarzyk PT, Ross R, (2004) Waist circumference and not body mass index explains obesity-related health risk. Am J Clin Nutr 79: 379-384.
12. Pouliot MC, Despres JP, Nadeau A, Moorjani S, Prud'Homme D, et al. (1992) Visceral obesity in men. Associations with glucose tolerance, plasma insulin, and lipoprotein levels. Diabetes 41: 826-834.
13. Janiszewski PM, Kuk JL, Ross R, (2008) Is the reduction of lower-body subcutaneous adipose tissue associated with elevations in risk factors for diabetes and cardiovascular disease? Diabetologia 51: 1475-1482.
14. Fujimoto WY, Bergstrom RW, Boyko EJ, Chen KW, Leonetti DL, et al. (1999) Visceral adiposity and incident coronary heart disease in Japanese-American men. The 10-year follow-up results of the Seattle Japanese-American Community Diabetes Study. Diabetes Care 22: 1808-1812.
15. Kuk JL, Katzmarzyk PT, Nichaman MZ, Church TS, Blair SN, et al. (2006) Visceral Fat Is an Independent Predictor of All-cause Mortality in Men. Obes Res 14: 336-341.
16. Lemieux I, Pascot A, Couillard C, Lamarche B, Tchernof A, et al. (2000) Hypertriglyceridemic waist: A marker of the atherogenic metabolic triad (hyperinsulinemia; hyperapolipoprotein B; small, dense LDL) in men? Circulation 102: 179-184.
17. Sam S, Haffner S, Davidson MH, D'Agostino RB Sr, Feinstein S, et al. (2009) Hypertriglyceridemic waist phenotype predicts increased visceral fat in subjects with type 2 diabetes. Diabetes Care 32: 1916-1920.
18. Arsenault BJ, Lemieux I, Despres JP, Wareham NJ, Kastelein JJ, et al. (2010) The hypertriglyceridemic-waist phenotype and the risk of coronary artery disease: results from the EPIC-Norfolk prospective population study. Cmaj 182: 1427-1432.
19. Expert Panel on Detection E, And Treatment of High Blood Cholesterol In Adults (2001) Executive Summary of The Third Report of The National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, And Treatment of High Blood Cholesterol In Adults (Adult Treatment Panel III). Jama 285: 2486-2497.
20. Lichtenstein KA, Ward DJ, Moorman AC, Delaney KM, Young B, et al. (2001) Clinical assessment of HIV-associated lipodystrophy in an ambulatory population. Aids 15: 1389-1398.
21. Blackburn P, Lemieux I, Lamarche B, Bergeron J, Perron P, et al. (2008) Type 2 diabetes without the atherogenic metabolic triad does not predict angiographically assessed coronary artery disease in women. Diabetes Care 31: 170-172.
22. Lo JC, Mulligan K, Tai VW, Algren H, Schambelan M, (1998) "Buffalo hump" in men with HIV-1 infection. Lancet 351: 867-870.
23. Carr A, Samaras K, Burton S, Law M, Freund J, et al. (1998) A syndrome of peripheral lipodystrophy, hyperlipidaemia and insulin resistance in patients receiving HIV protease inhibitors. Aids 12: F51-58.